The practical answer
Choose method evidence according to the analytical question, sample matrix and laboratory using the procedure. Validation establishes fitness for a defined purpose; verification checks relevant performance when implementing an established compendial procedure; transfer addresses use at another laboratory. An instrument name or a supplier's method number cannot replace this assessment.
Start with the decision and sample, not the instrument
Write an analytical brief that identifies the attribute, material, concentration range and release decision. Measuring total magnesium in a raw ingredient is different from detecting a low-level contaminant or distinguishing a chelate from a physical mixture. A method suitable for one purpose may not support another claim.
For US dietary supplements, 21 CFR 111.320 requires verification that laboratory methods are appropriate for their intended use and the use of scientifically valid methods for established specifications. This is the relevant regulatory starting point for supplement teams. [1]
Distinguish the three work packages
USP <1226> describes verification as assessing selected performance characteristics when a compendial procedure is first used with the laboratory's available personnel, equipment and reagents; it does not mean repeating the complete validation automatically. Confirm that the procedure is genuinely applicable to the material before choosing this route. [2]
ICH Q2(R2) offers a framework for validation, including specificity, range, accuracy and precision. Its formal scope is pharmaceutical analytical procedures. Supplement teams can use the scientific concepts when appropriate, but should not describe every ICH recommendation as a supplement regulation. [3]
| Work package | Core question | Useful deliverable |
|---|---|---|
| Validation | Does this procedure perform adequately for its defined purpose? | Approved protocol, acceptance criteria, results and conclusion |
| Compendial verification | Does the applicable established procedure work under our conditions? | Selected performance evidence and justification of scope |
| Transfer | Can the receiving laboratory implement the method suitably? | Agreed transfer approach, comparison evidence or justified alternative |
| Routine suitability checks | Is this analytical run acceptable under the procedure? | Run controls, acceptance decision and retained data |
On smaller screens, scroll the table horizontally.
Make the laboratory request specific to magnesium ingredients
Ask the laboratory to map each claimed attribute to a suitable method. For a total-magnesium assay, the practical review might examine preparation completeness, calibration range, dilution and reporting basis. For an identity procedure, ask what relevant alternative materials it can distinguish. For an impurity limit, ask whether useful quantitative performance extends to the decision level.
Set acceptance criteria before examining the final data. Avoid a generic recovery or precision limit copied from an unrelated assay. The acceptable error depends on the specification, concentration and consequence of an incorrect release decision. Treat the following as questions to resolve with the laboratory, not a fixed validation protocol.
- Which reference materials and comparison samples support the claimed measurement?
- Does the evidence cover this raw ingredient, a finished blend, or both?
- Which sample-preparation steps are most sensitive to analyst technique?
- How are water correction, dilution factors, units and rounding controlled?
- What changes in instrument, matrix or preparation trigger reassessment?
Connect transfer evidence to the release specification
When moving testing between laboratories, agree on samples, method version, reporting basis and comparison criteria before shipment. ICH Q14 discusses risk-based bridging for analytical changes, including transfer to a different site. The amount of work should address the changes and uncertainties involved, not simply repeat a standard number of samples. [4]
A useful procurement handoff contains the approved method reference, its scope, the receiving laboratory's conclusion and the specification it supports. Store unresolved discrepancies with an owner and closure date. Request this evidence package early when qualifying a magnesium ingredient so that method alignment does not become a last-minute production delay.
Common questions
Does an accredited laboratory make every result fit for our purpose?
No. Review the particular method, matrix, concentration range and intended decision. Laboratory credentials and method suitability answer related but different questions.
Must every compendial method undergo full validation again?
Not automatically. Establish applicability and determine the verification work needed under actual laboratory conditions. Modified procedures or a different matrix may require additional evidence.
Can an ICP method validate a fully chelated claim?
A total-element ICP method measures magnesium concentration, not chelation completeness. A chelation claim needs a defined meaning and suitable complementary composition and identity evidence.
Sources & further reading
- 21 CFR 111.320: Requirements for laboratory methods
- USP <1226>: Verification of Compendial Procedures, public introduction
- FDA / ICH Q2(R2): Validation of Analytical Procedures, sections 1–3
- FDA / ICH Q14: Analytical Procedure Development, section VII and table 2